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1. Introduction
1.1. The definition of caloric restriction therapy
Caloric restriction (CR) is to treat some diseases by restricting the intake of calorie or the content
of a particular ingredient of the diet, while ensuring the basic nutritional need [1]. It was used
to increase average and maximum lifespan in ancient times [2], however, in last 100 years CR
effect on improvement of T2DM has been established by many researchers, because it can
improve the metabolic parameters and pancreas islet function of type 2 diabetic patients [3].
The treatment efficacy and safety has been clear.
1.2. The main forms of caloric restriction therapy
Nowadays, CR is only used in basic and clinical researches, and its form is disunity. The earliest
form of this method used in the study is called fasting, which means apastia, and the partici‐
pators should never eat anything except drink water. This method was eliminated because of
its uncertain adverse reactions [4]. According to the different restricted objects of CR, it can be
divided into low-calorie restriction diet, low-carbohydrate restriction diet, low-fat restriction
diet and so on; according to the different frequency of CR, we can divide it into continuous
CR, intermittent CR (followed CR for 2 days per week and normal diet at the other times) or
every other day CR (followed CR one day and a normal diet the next day); and it can also been
divided into short-term CR (≤9 days) and long-term CR (>9 days) according to the length of
restriction duration. Moreover, low-calorie restriction could be divided into low-caloric diet
(LCD) and very-low-caloric diet (VLCD). All of them may improve the state of T2DM, control
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the blood glucose stably and reduce its morbidity, but the differences of the treatment efficacy
among them are not clear until now.
2. The preventive effect of CR on T2DM
As a lifestyle intervention method, it is very important to make sure whether this thera‐
py can prevent T2DM from occurrence in the high risk persons. Tuomilehto et al. [5] had
assigned 552 middle-aged, overweight subjects with impaired glucose tolerance to either
the intervention group or the control group. Each subject in the intervention group received
individualized  counseling  aimed  at  reducing  weight,  total  intake  of  fat,  and  intake  of
saturated fat  and increasing intake of fiber and physical  activity.  After 3.2 years follow-
up, they found that the cumulative incidence of diabetes was 11 percent (95% confidence
interval, 6% to 15%) in the intervention group and 23% (95% confidence interval, 17% to
29%) in the control group, moreover, during the trial, the risk of diabetes was reduced by
58% (P<0.001) in the intervention group. The next year, another larger sample follow-up
study focused on the lifestyle intervention on diabetes prevention, including CR, exercise,
et al. Three years follow-up later, CR reduced the incidence by 58% (95% confidence interval,
48% to 66%), as compared with placebo [6]. These studies provided satisfactory evidences
on the preventive effect of CR on T2DM.
3. The therapeutical effect of CR on T2DM
3.1. The short-term therapeutical effect of CR on T2DM
CR has shown to be helpful for the blood glucose control and the improvement of pancreatic
islet function. It produces multiple beneficial effects on metabolic parameters in type 2 diabetic
patients by virtue of both calorie restriction and weight loss. Animal experiments confirmed
that CR regulates the process of glucose metabolism in a variety of tissues (adipose tissue, liver,
pancreas, skeletal muscle, et al) [7]. In clinical trials, the blood glucose of the participators
decreased to normal range within a few days, and to the lowest point after 1-2 weeks [8]. In
another short-term study of 14 obese patients with T2DM using VLCDs, marked improvement
was seen in glycosylated HbA1c [9]. It fell from 7.4±0.3% to 6.0±0.2% after 8 weeks VLCD [10].
As a consequence, CR was thought to improve glucose metabolism in type 2 diabetics. Besides,
the fasting plasma insulin/C-peptide levels of patients with T2DM fell after CR, and thus
improved the insulin sensibility [11]. Generally, Blood pressure, triglycerides, total cholesterol
and LDL-C were reduced, while only HDL-C varied [12, 13].
3.2. The long-term therapeutical effect of CR on T2DM
Whether CR improves the state of T2DM for a long time has been the major concern for
many researchers. Unick et al. [14] chose 5145 type 2 diabetic patients randomized to an
intensive lifestyle intervention and diabetes support and education. The lifestyle interven‐
Treatment of Type 2 Diabetes186
tion group received a behavioral weight loss program that included group and individu‐
al  meetings,  a ≥10% weight loss goal,  calorie restriction,  and increased physical  activity.
Diabetes support and education received a less intense educational intervention.After four
years follow-up, body weight, blood glucose and lipid profile improved significantly in the
intervention group, suggesting that CR may obtain an optimal long-term metabolic control
in T2DM patients.
Because of the poor compliance of patients with long-term CR, there are few researches in
this area, and more researchers begin to concentrate on the long-term effect of short-term
CR on T2DM patients. In a clinical study, 40 obese patients with T2DM and symptomatic
hyperglycaemia were selected despite combination oral anti-diabetic therapy+/-insulin, and
given 8 weeks of VLCD therapy (750kcal/d), followed by standard diet and exercise advice
at 2-3 month intervals up to 1 year [15]. After 8 weeks of VLCD, body weight and body
mass index (BMI) fell significantly, with favourable reductions in blood pressure, fructosa‐
mine and HbA1c. Sustained improvements were evident after 1 year, with minimal weight
regain. Unexpectedly, glycemic control tended to deteriorate. In another study, 18 insulin-
treated T2DM patients were treated with 30 days VLCD (450kCal/day) with the cessation
of all  glucose-lowering medication, and then followed for 18 months [16].  Caloric intake
was  slowly  increased  to  eucaloric  and  glucose-lowering  medication  can  be  restarted  if
necessary. After 18 months follow-up, the use of insulin was significantly reduced: 18 out
of 18 patients on day 0,  5 out of  18 patients at  18 months.  Moreover,  although patients
using insulin at 18 months had regained weight a little, but still had a better cardiovascu‐
lar risk profile compared with this parameter before CR (Table 1). In spite of favourable
outcomes,  these shorter  term CR studies still  require more data to clarify the long-term
therapeutical effect of CR on metabolic disorders.
3.3. The studies of special crowd for CR
Metabolic disorders including obesity and diabetes are more prevalent in children and
adolescents. However, most of them cannot obtain a satisfactory blood glucose control since
pharmacologic agents currently approved for use in children and adolescents with T2DM
(metformin and insulin) are less optimal. Therefore, in hope of a better glucose control in
children, lifestyle intervention attracted many interests. A chart review of 20 children (mean
age 14.5±0.4 years) who consumed a ketogenic VLCD in the treatment of T2DM was conducted
[17]. Eventually, VLCD allowed insulin and oral agents to be discontinued in all but one subject
who was not compliant, and no other subjects required resumption of medications during the
course of the diet on the condition that the metabolic parameters such as blood glucose and
blood pressure were well controlled. More importantly, this study monitored the metabolic
profiles to ensure that the patients were not at risk for developing electrolyte disturbances or
ketoacidosis. Fortunately, none experienced nausea, vomiting, dehydration, or other side
effects, such as orthostatic dizziness, muscle cramps, fatigue or halitosis previously reported
in pediatric studies.
The efficacy and safety of CR in the elderly were also investigated. Recently, a total of 5145
individuals with T2DM (1053 aged 65 to 76 and 4092 aged 45 to 64) were chosen to compare
The Preventive and Therapeutic Effect of Caloric Restriction Therapy on Type 2 Diabetes Mellitus
http://dx.doi.org/10.5772/59281
187
the effects of 4 years of intensive lifestyle intervention in older and younger individuals [18].
Both groups were respectively divided into two subgroups and given either lifestyle inter‐
vention (include CR and exercise) or health education. After 4 years follow-up, lifestyle
intervention was favourable to a better control of blood glucose, blood pressure. Surprisingly,
the elderly group gained more benefits than the younger group. Therefore, CR may be
considered to be a treatment to metabolic disorders.
4. The mechanism of CR of treating T2DM
In recent years, a number of studies have expounded the possible mechanisms from different
sides of the CR studies.
4.1. Weight loss
It was thought that the effect of CR on blood glucose was similar to bariatric surgery, because
both of them base on weight loss. Insulin sensitivity and blood glucose are improved after
weight loss. However, it is still uncertain. An important issue is that blood glucose of patients
fell before weight loss during 40 days VLCD [19]. Studies haven’t been consistent with the
effect of CR on obese patients with type 2 diabetes either. Bergman et al. [20] had compared
the effect of CR on patients with normal BMI (22.8±0.42kg/m2) and obesity (36.1±1.548kg/m2),
and found that both groups had a drop of hepatic glucose production volume after 12-48 hours
CR, with a better improvement of the insulin sensitivity in normal BMI group. Recently, Unick
et al. [14] divided the participators into overweight group, mildly obese group, moderately
obese group and severely obese group according to their body weight, then they were treated
with CR. The result showed that the overweight group lose less weight than other groups, but
the change of other metabolic indicators was similar. This may show the change of body weight
and metabolic indicators is not always parallel. So whether the effect of CR on the control of
blood glucose was dependent on the weight loss is unclear now.
4.2. Glycometabolism
Firstly, CR inhibits gluconeogenesis, leading to the decrease of hepatic glucose output, thus
reducing the glucose source; it increased fatty acid oxidation in the liver, and then produces
ketones, which can improve the tolerance of hungry by inhibiting the appetite impulsion from
hypothalamus; glucose metabolism and consumption in liver and muscles also increase after
CR [21]. Secondly, CR increases the insulin sensitivity and reduces insulin resistance. When
patients were recruited to evaluate the effect of VCLD, insulin resistance index significantly
decreased eventually [22, 23]. However, it is still controversial. No contribution of CR on
insulin sensitivity was found after 14 severely obese patients with T2DM were treated with
VLCD for 7 days [10]. The short duration of VLCD and special population chosen may be
responsible for this unsatisfactory result. Finally, CR improves pancreas islet function. The
insulin secretion and the area under the insulin curve of OGTT increased after CR [24]. The
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first phase insulin secretion, which represents acute insulin response, increased after CR as
well. Therefore, CR was thought to improve pancreas islet function.
Figure 1 shows the effects of CR on glycometabolism. CR leads to glycogen depletion in muscle
and liver, and restriction of carbohydrate leads to lipolysis and the formation of ketone bodies
by the liver. Together, hepatic glucose output is reduced via inhibition of gluconeogenesis and
glycogenolysis. Meanwhile, high protein stimulates insulin secretion and increases satiety.
Circulating ketone bodies probably contribute to tolerability of the diet by suppressing
appetite in the hypothalamus. Weight loss and diminution of fat depots in the liver, muscle
and peri-visceral space lead to reductions in insulin resistance. Improved insulin sensitivity,
dynamic insulin secretion and reduced hepatic glucose output lead to reductions in blood
glucose levels.
Figure 1. The effects of calorie restriction on glycometabolism. VLCD, very low calorie diet; CHO, carbohydrate.
4.3. Inflammatory response and oxidative stress
CR is “a new environment” to the human body. It causes lower blood glucose, insulin level,
fat content and body weight. This helps human more tolerant to stress, thus some chronic
diseases (T2DM, et al) could be prevented or treated [25]. Figure 2 has shown the effects of CR
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on oxidative stress. CR results in an increase in the level and activation of _adenine nucleotide
translocase (ANT) and uncoupling protein (UCPs) to reduce the mitochondrial membrane
potential, which induces a decrease in superoxide radical production at complex 1 of the
electron transport chain. Less damage to the lipids in the mitochondrial membrane is further
reduced by increases in the membrane lipid saturation. Increases in superoxide dismutase
convert superoxide into hydrogen peroxide and increased levels of glutathione peroxidase
(GPX) and catalase convert this to water reducing the product of the toxic hydroxyl radical
(OH-) [26]. Lower levels of OH reduce the oxidative damage to proteins and DNA, which is
further ameliorated by enhanced levels of degradation and base excision repair respectively.
Animal experiments also confirmed that the oxygen free radicals in mice reduced and the β-
hydroxybutyrate, which could act as an antioxidant, was increased after CR. In some clinical
studies, some inflammatory factors (such as tumor necrosis factor-α, interleukin-6, interleu‐
kin-8) decreased significantly after CR.
Figure 2. The effects of calorie restriction on oxidative stress.
4.4. Adiponectin
In 2011, Qiao et al. [27] found adiponectin gene expression increased in CR mice. Adiponectin
in circulation could regulate various metabolic processes, including anti-inflammatory, insulin
sensitivity and resistance, et al. It becomes another possible mechanism.
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5. The differences among various forms of CR
Nowadays, the regime of CR in various studies is still not uniform. This causes imparity of CR
effect. A systematic review published in 2004 showed that a very low calorie diet was associ‐
ated with the most weight loss after 12 months in one small study with beneficial effects on
asthma. There was no evidence that low carbohydrate diets were associated with greater long-
term weight loss than low calorie diets. Nevertheless, they were associated with greater
lowering of fasting plasma glucose and HbA1c than low calorie diets, with more adverse
events, such as increasing risk of arhythmia, osteoporosis or kidney stones [28]. Until now,
there are few evidences from large-scale follow-up studies to clarify the differences among
various CR forms.
6. The adverse reactions of CR
Strict caloric restriction may increase risk of hypoglycemia. There are not enough evidences
that CR causes arrhythmia or electrolyte disorders in the studies reported until now [29]. The
risk of gallstones may be higher in the first few days because of inadequate intake of fat. Bone
density decreases during CR without any data showing it increases fracture risk. The most
remarkable adverse reaction is increase of uric acid during CR, but only few study found it
induced gout. CR may induce the onset of ketosis, which may depend on the total intake of
carbohydrate rather than calorie [30]. However, the level of ketone bodies in serum during CR
is generally 0.33-0.71mmol/l, which is far below the level during ketoacidosis (>25mmol/l),
even though it is abnormal.
Other possible adverse effects include mild dizziness, headache, fatigue, cold, dry skin,
transient rash, changes of defecate habits, hair loss, cramps, menstrual disorders and short-
term elevated transaminases [31]. Yet for all that, these adverse effects are all slight, and can
be treated easily. Generally, CR is relatively safe in patients with type 2 diabetes, but more
long-term adverse effects needed to be observed.
7. The prospect forecast of CR used in T2DM
As a type of lifestyle interventions, CR may play a pivotal role in the therapeutic strategy to
maintain optimal glycemic control and prevent complications in the patients with type 2
diabetes. In the light of the unreasonable lifestyle nowadays, CR should be paid enough
attention to because it provides more choices for the prevention and treatment of T2DM.
Existing studies cannot ensure uniform regime of CR for different state of T2DM. Large-scale
and forceful researches are required to clarify the differences among all the forms of CR and
the long-term adverse effects.
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